The University of Chicago Header Logo

Bevacizumab or laser for aggressive posterior retinopathy of prematurity.

Bevacizumab or laser for aggressive posterior retinopathy of prematurity. Taiwan J Ophthalmol. 2018 Oct-Dec; 8(4):243-248.

View in: PubMed